Michigan Medicine News

RSS Feed

Clinical trial will treat glioblastoma in pet dogs

October 20, 2017

A new immunotherapy approach to a devastating brain cancer is going to the dogs, thanks to a neurosurgery, pediatrics and veterinary collaboration.Maria Castro, Ph.D., professor of neurosurgery at Michigan Medicine, received…

Michigan Medicine named Best and Brightest ‘elite winner’ for employee recognition programs

October 18, 2017

Michigan Medicine has once again been named one of the “Best and Brightest” companies to work for in Metropolitan Detroit. The recognition was handed down by the National Association of Business Resources for the organization’s commitment to excellence in human resources and employee enrichment. In fact, Michigan Medicine was deemed an “elite winner” for its employee achievement and recognition programs. “Our employees are incredibly dedicated and committed — making it a privilege for us to recognize everything that they do,” said Rich Holcomb, acting chief human resources officer. “I am confident that our faculty and staff’s hard work and talent…

U-M program helps young adults with disabilities get ready for workforce 

October 10, 2017

https://www.youtube.com/watch?v=PMla-AhCFSE Colton Schick has always enjoyed cooking. “It’s just fast-paced,” the 20-year-old said, “and that’s what I like.” And now, the pursuit also gives him a sense of pride. Colton is…

U-M’s Fast Forward Medical Innovation receives EDA grant

October 10, 2017

U.S. Secretary of Commerce Wilbur Ross recently announced that 42 organizations from 28…

MedEQUIP update

October 2, 2017

Please be advised that in early October, MedEQUIP — Michigan Medicine’s durable medical equipment provider — will stop accepting new patients for many of the services it currently provides. There are a few therapies that should continue serving new and established patients uninterrupted; including: LVAD supplies Home ventilators and other associated supplies for adult and pediatric patients in this program Serum ketone testing supplies for ketogenic diet pediatric patients Inpatient specialty beds UV light blankets (AKA: “Bili Blankets”) Cochlear processors Effective immediately, refer patients to outside DME suppliers when applicable. Thanks in advance for your cooperation. If you have more…

1 in 3 older adults take something to help them sleep – but many aren’t talking to their doctors

September 27, 2017

Sleep doesn’t come easily for nearly half of older Americans, and more than a third have resorted to some sort of medication to help them doze off at night, according to new results from the National Poll on Healthy Aging. But most poll respondents said they hadn’t talked to their doctor about their sleep, even though more than a third said their sleep posed a problem. Half believe — incorrectly — that sleep problems just come naturally with age. The poll was conducted by the U-M Institute for Healthcare Policy and Innovation, and is sponsored by AARP and Michigan Medicine. Those…

‘Flights of Fancy’ artwork on display at Taubman

September 21, 2017

Since Ellie Harold started painting in 2003, she has primarily been a landscape artist, painting Michigan barns and lake shore scenes in oil. In November 2016, following a trip to Mexico, birds…

Michigan Medicine researchers awarded nearly $3.5 million to fight fatigue in multiple sclerosis

September 19, 2017

A new clinical trial will explore three interventions in improving one of the most disabling symptoms for people…

FDA approves new antibiotic drug for UTIs

September 14, 2017

Work by Keith Kaye, M.D., M.P.H., director of clinical research in the Michigan Medicine Division of Infectious Disease, helped fast-track the approval of a new drug for antibiotic-resistant urinary tract infections (UTIs).The drug, Vabomere, was approved to treat complicated UTIs, including pyelonephritis, a potentially life-threatening infection caused by bacteria traveling from the bladder into one or both of the kidneys.Kaye was principal investigator of the TANGO-2 trial which showed Vabomere improved clinical cure rates and resulted in less harm to kidneys compared to the best available therapy. The Food and Drug Administration fast-tracked the new drug, giving it priority review.The…